Who has invested in Progentos Therapeutics?

Forbion, Alta Partners, Mission BioCapital, Longwood Fund, Dolby Family Ventures are named among the investors backing Progentos Therapeutics.

Progentos Therapeutics Funding: $65M Raised, Series A (2024)

Progentos Therapeutics funding overview

Progentos Therapeutics is a Biotech company based in Watertown, MA. Progentos Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2024. The round record for Progentos Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Forbion, Alta Partners, Mission BioCapital, Longwood Fund, Dolby Family Ventures. 5 distinct backers are named across the disclosed rounds.

Progentos Therapeutics at a glance

Total raised: $65M
Latest round: Series A
Latest round date: May 2024
Industry: Biotech
Headquarters: Watertown, MA
Notable investors: Forbion, Alta Partners, Mission BioCapital, Longwood Fund, Dolby Family Ventures

Frequently asked about Progentos Therapeutics funding

How much has Progentos Therapeutics raised?: Progentos Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Progentos Therapeutics?: Forbion, Alta Partners, Mission BioCapital, Longwood Fund, Dolby Family Ventures are named among the investors backing Progentos Therapeutics.
What was the latest Progentos Therapeutics funding round?: The most recent disclosed round is a Series A, announced in May 2024.
Where is Progentos Therapeutics based?: Progentos Therapeutics is based in Watertown, MA.
What sector does Progentos Therapeutics operate in?: Progentos Therapeutics is tracked under Biotech from Watertown, MA, with $65M in disclosed funding.
When did Progentos Therapeutics last raise?: The last disclosed Progentos Therapeutics round closed in May 2024 at Series A.

Round data for Progentos Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Watertown and backer lists below.

Progentos Therapeutics Funding: $65M Raised, Series A (2024)

Progentos Therapeutics funding overview

Progentos Therapeutics at a glance

Frequently asked about Progentos Therapeutics funding

Progentos Therapeutics founders (1)

Companies related to Progentos Therapeutics (40)

Browse related funding lists (7)